Mylan Competitors and Similar CompaniesClear all
Amgen's competitors and similar companies include BioMarin Pharmaceutical and Alkem Laboratories.
 Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. |  BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. | ||
Founding Date | Founding Date 1980 | Founding Date 1997 | Founding Date 1973 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations HQ Mumbai, IN Almaty, KZ Makati, PH |
Employees | Employees 25,200 | Employees 3,0015% increase | Employees 14,331 |
Valuation ($) | Valuation ($) 170.4 b | Valuation ($) 13.3 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $12b (FY, 2025) | Cost of goods $717.4m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $24.7b (FY, 2025) | Gross profit $2.5b (FY, 2025) | Gross profit N/A |
Net income | Net income $7.7b (FY, 2025) | Net income $348.9m (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Phase III Trials Products | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products 2 (FY, 2016) | Phase III Trials Products N/A |
For sources of this data, please see the company profile
View Company Profiles
BioMarin Pharmaceutical
HQ
San Rafael, US
Employees
3,001↑ 5% increase
BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
View company
Alkem Laboratories
HQ
Employees
14,331
Alkem Laboratories is a pharmaceutical company that operates globally.
View company